Fig. 2

Abnormal regions identified in an AES–SDM meta-analysis in acute lymphoblastic leukemia (ALL) patients post-chemotherapy. Regions showing decreased activation in ALL patients post-chemotherapy compared with healthy controls (HCs) are highlighted in red